NX1 — Nexalis Therapeutics Share News
0.000.00%
- AU$2.28m
- AU$2.21m
- AU$0.99m
Australia Stock Exchange release from INHALERX : PRE_NR Ends: 10:13:36
Australia Stock Exchange release from INHALERX : Quarterly Appendix 4C Cash Flow Report
Brief: Inhalerx Says Matthew Golden Resigns As Chief Executive Officer
Australia Stock Exchange release from INHALERX : PRE_NR Ends: 09:46:55
Australia Stock Exchange release from INHALERX : InhaleRx Ltd appoints Executive Director
Australia Stock Exchange release from INHALERX : Change in substantial holding
Australia Stock Exchange release from INHALERX : Change of Director's Interest Notice
Australia Stock Exchange release from INHALERX : Securities Trading Policy
Australia Stock Exchange release from INHALERX : PRE_NR Ends: 08:50:51
Australia Stock Exchange release from INHALERX : Quarterly Activities Report
Australia Stock Exchange release from INHALERX : PRE_NR Ends: 08:47:46
Australia Stock Exchange release from INHALERX : Appendix 4C Cash Flow Report
Australia Stock Exchange release from INHALERX : Change of Share Registry Details
Australia Stock Exchange release from INHALERX : Change of Registered Office Address
Australia Stock Exchange release from INHALERX : Change in substantial holding
Australia Stock Exchange release from INHALERX : Change of Director's Interest Notice
Australia Stock Exchange release from LIFESPOT HEALTH : Company Name Change and New ASX Code 'IRX'
Australia Stock Exchange release from LIFESPOT HEALTH : Results of Meeting
Australia Stock Exchange release from LIFESPOT HEALTH : EGM Presentation